Psoriatic Arthritis
News
FDA advisory panel unanimously backs biosimilars for Humira, Enbrel
Conference Coverage
Severe psoriasis upped lymphoma risk in large cohort study
SCOTTSDALE, ARIZ. – Psoriasis of all severities was linked to a 3.5-fold increase in risk of cutaneous T-cell lymphoma, and severe psoriasis upped...
Conference Coverage
Analysis supports daily folate for children with psoriasis on methotrexate
Key clinical point: Consider daily folate to reduce the likelihood of gastrointestinal side effects of methotrexate in children with psoriasis....
News
Significant race and health care disparities exist among hospitalized psoriasis patients
Conference Coverage
Obesity may attenuate anti-TNF response in psoriatic arthritis
LONDON – Patients with psoriatic arthritis appear less likely to achieve a good response to their first anti-tumor necrosis factor therapy if they...
News
TB still a risk in psoriasis patients taking TNF blockers
Key clinical point: Individuals with psoriasis treated with tumor necrosis factor inhibitors may still present with tuberculosis, despite...
News
TNF blocker safety may differ in RA and psoriasis patients
RA patients on anti-TNF medications had approximately twice the rate of serious adverse events as did psoriasis patients on the same medications,...
News
Full resolution of psoriasis in half of ixekizumab patients
Half of patients treated with the IL-17A–neutralizing ixekizumab achieve full resolution of psoriasis plaques after 1 year.
Conference Coverage
Serious infections are increasing among psoriasis inpatients
Key clinical point: Psoriasis is an independent risk factor for serious infections, and serious infections are increasing among inpatients with...
News
Brodalumab effective for rare, severe types of psoriasis
Key clinical point: The interluekin-17 inhibitor brodalumab significantly improved symptoms of generalized pustular psoriasis and psoriatic...
Conference Coverage
Effective psoriasis therapy may reduce coronary plaque burden
Key clinical point: Improved PASI scores were linked to regression of early noncalcified coronary plaque. Major finding: Reduction in skin...